Prostate Cancer

Artificial intelligence (AI) is being used in a wide variety of fields and circumstances today, ranging from financial analysis, educational tutoring, aviation stimulators, and robotics. Medical research is another hot area, and recently one of the many questions investigators have asked is, can artificial intelligence help predict prostate cancer progression after surgery? Even though prostate…

Scientists have been looking at the increased cancer risk in Parkinson’s disease patients for years, particularly skin cancers and melanoma.  Now, University of Utah School of Medicine researchers have found evidence to suggest a link between Parkinson’s disease and prostate cancer risk and that the risk extends to both close and distant relatives with Parkinson’s….

A new prostate cancer gene test can reduce the number of men who need prostate cancer surgery. Genomic Health announced the availability of the Oncotype DX prostate cancer test. The test can strongly predict disease aggressiveness, helping patients and physicians make more informed decisions about how to proceed with prostate cancer treatment. Oncotype DX is…

I have posted numerous blogs on the risk of aggressive prostate cancer (PCa) for men who are overweight. Once again, research bears this out. A new Canadian study involved 51 patients scheduled for a prostate biopsy who were first evaluated for factors related to body composition and metabolism. Once the biopsy results were in, the…

Prostate cancer ranks among the most frequent types of cancer in males. Physicians have tried to minimize the risk by including prostate examination in most men’s annual medical examination, but that’s not enough. Unfortunately, the majority of men don’t not know that they should be watchful and check for certain indications that betray prostate cancer…

From a field of 156 candidate genes, scientists have discovered five genetic markers significantly associated with aggressive prostate cancer. This is an important find, not only because it may help clinicians identify which men are at greatest risk of dying of prostate cancer, but also because it could help researchers develop a simple blood test…

Today’s world of prostate cancer (PCa) is a far cry from what it was in your dad’s day. New knowledge about the disease includes a better understanding of prostate anatomy, PCa genomics, the behavior of cancer cells, the role of lifestyle, etc. However, some old beliefs still linger. It’s time to put them to rest….

A new prostate cancer test is available to doctors and patients. Genomic Health announced the availability of Oncotype DX Prostate Cancer Test at the American Urological Association (AUA) Annual Meeting in San Diego. The new prostate cancer test is the first of its kind. This multi-gene test will help guide treatment decisions, allowing patients with…

We all know that high cholesterol increases the risk of heart disease, right? But guess what–it’s a risk factor for prostate cancer. And not just prostate cancer; studies have linked high total cholesterol (“good” plus “bad” cholesterol) with cancer of the colon, testicles and rectum. Cholesterol is one of the fatty substances called lipids that…

African-American prostate cancer is often more aggressive than diagnosed according to the latest studies. Black men need to follow their prostate cancer more closely and may need different diagnosis and treatment plans from white patients. According to a Johns Hopkins study (published in the Journal of Clinical Oncology) of more than 1,800 men ages 52 to 62, African-American men…

Late stage prostate cancer symptoms may include urinary symptoms as well as pain or fatigue. While screening has led to improved diagnosis and treatment of prostate cancer, 5% to 10% of newly diagnosed patients have initial late stage prostate cancer symptoms. Most patients diagnosed in early stages do not have symptoms, but patients more commonly experience…

Men diagnosed with prostate cancer often ask, how is prostate cancer measured? The most commonly used system to measure prostate cancer is the American Joint Committee on Cancer TNM system. This approach helps physicians and patients monitor and treat prostate cancer. Here’s an answer to how prostate cancer is measured. Prostate cancer stages The TNM…

Inflammatory bowel disease (IBD) affects approximately 3 million people in the United States, and if you are among them and are male, you should know this: researchers have noted a relationship between IBD and prostate cancer in men. Here’s what experts know thus far. IBD and prostate cancer Past research has shown that people who…

At first, the United States government said there was no connection between  the Agent Orange sprayed during the Vietnam War and the increased appearance of prostate cancer among veterans. Then, in 1996, the Institute of Medicine concluded its report, “Veterans and Agent Orange: Update 1996,” and admitted there was credible evidence of a positive association…

First, the good news: the number of cases of prostate cancer overall does not appear to be increasing. However, new research from Northwestern University indicates that new cases of metastatic prostate cancer (the type that has spread beyond the prostate) has risen 72 percent between 2004 and 2013. Men between the ages of 55 and…

I have previously written several blogs about the correlation between lifestyle choices (diet, exercise, supplements, etc.) and the risk of prostate cancer (PCa). There is ample evidence that healthy choices can reduce risk by helping the genes that discourage tumor growth. On the other side, there are also plenty of studies that show a connection…

Experts report a significant decline in prostate cancer incidence and deaths, according to study results presented at the American Association for Cancer Research Annual Meeting held in Atlanta March 29 to April 3, 2019. Of the 44 countries evaluated for incidence data, the United States showed the largest decline in cancer rates among the seven…